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Introduction 
CityWide works to promote and support a community development approach to the 
drugs problem - this means involving the people who are most affected by the 
problem in dealing with the problem - drug users, their families and communities.   
Citywide provides networks through which local communities can develop 
coordinated responses to issues of drug policy and services. We work with 
communities to develop responses to the drugs problem in their area, by providing 
ongoing support.  We support best practice in drug treatment and the development 
of all protocols that assist in easing and reducing the pain and destruction drug use 
does to individuals, families and our communities.  The promotion of effective 
engagement between methadone prescribing services and community services is an 
important element of CityWide‟s work.   
 
CityWide is clear that methadone has been a very useful element of drug treatment 
in Ireland.  But we are equally clear that it is not a treatment in itself.  Methadone 
should be used as part of an overall care plan for drug users; this intervention should 
include all other elements required for progression in recovery  
 
Methadone is a powerful drug.  It brings powerful changes to individuals, families 
and to communities.  It also brings power to those who prescribe and those who 
provide services within its treatment.  Such power can be a force for good and a 
force for abuse.  Community service providers have experienced both aspects of 
methadone‟s power and Citywide encourages all developing this protocol to 
remember the power dynamic involved with the prescribing of methadone, at all 
levels. 
1. Access to treatment 
1.1: Reducing waiting times for access to treatment to within one month of initial 
assessment has been a priority action in the National Drugs Strategy, 2001-2008 
and in the current NDS, 2009 – 2016 (action 32). Despite these priority actions, 
waiting lists for methadone services continue to exist.  In Dublin, Trinity Court 
frequently reports waiting lists of 4 months and more.  Outside Dublin the waiting 
lists are even greater with recent reports (Irish Examiner, April 27th 2010) of 450 
people nationwide on methadone waiting lists - Athlone and Portlaoise, reporting 
over 100 people waiting for more than seven months; in Drogheda 15 people are on 
a waiting list for 15 months; in Waterford more than 40 people have been waiting for 
two years.  As a result many people are travelling to avail of services in Dublin which 
in turn overloads these services. 
  
Opiate users who are motivated to engage with treatment services must be given 
access to those services within one month irrespective of where they live. Service 
providers have noted that motivation to seek treatment diminishes with stimulant use 
(crack cocaine in particular) and clients need to be linked to treatment services while 
they are still motivated.  
 
It may be that the system is already at capacity.  However, there are no guidelines in 
the current protocol that offer suggestions for what capacity is for a methadone 
service and what a service should do once it reaches capacity.  GPs are given limits 
to the numbers they are permitted to treat; clinics should be given similar limits so 
that appropriate treatment may be delivered to clients. 
 
We suggest that guidelines for best practice in relation to numbers attending 
methadone clinics are included in the protocol so that the NDS can be appropriately 
completed – with, as a corollary to this point,  new services need to be opened 
where demand exceeds supply. 
 
1.2: Allied to the need for a reduction in waiting times for treatment is the 
requirement for needle exchange services to be provided.  The aim in the National 
Drugs Strategy is to provide “…an integrated treatment and rehabilitation service that 
provides drug free and harm reduction approaches for problem substance users; and 
to encourage problem substance users to engage with, and avail of, such services” 
(National drug Strategy, 2009-2016, page 7). 
 
We suggest that the provision of methadone services must include widely available 
and flexible easily accessible needle exchange equipment, advice and services.  To 
date, for many IV drug users, the MQI exchange is the only service available.  This is 
both counter-productive to the purpose of methadone provision and likely to increase 
the numbers of more difficult problems including poor injecting practices, HCV and 
HIV. 
 
2. Coherence and co-ordination of treatment at operational level 
2.1: In the main community drug services and projects are not consulted or informed 
by prescribing GP‟s on the care or treatment of their clients.  There are a number of 
notable exceptions where joint working protocols have been developed locally for the 
care of clients (see appendix).  Local protocols on agreed shared care of clients 
should be implemented in all areas.  
 
Action 32 of the National Drugs Strategy is to develop a comprehensive 
integrated national treatment and rehab service for all substance users using a 
4-tier model approach.  Multi-disciplinary teams should be developed to operate 
case management which should include the prescribing GP‟s and the projects who 
work closely and daily with the client in supporting their treatment, detox and 
rehabilitation.   
 
Case management would allow for prescribing rationale to be discussed; all clients 
should have a right to have a nominated person (a Service Users Advocate) to be 
involved in their care plans.  
 
CityWide is cognisant of the fact that GPs are under many constraints arising from 
medical and employment restrictions regarding inter-agency dialogue about cases.  
However, should a case management approach be adopted, we believe that GPs 
and clinic staff will find that the expertise and insight brought to the table by the 
community sector will add to the effectiveness of the work and reduce overall work-
load with clients and GPs and their staff net beneficiaries.   
2.2: Not all clients need to be seen every week.  In Britain the protocol calls for a 
community team to meet the client every 2 weeks to assess them on a formal basis 
and discuss progress of their plan and make recommendations for continued 
dosage.  We believe that similar arrangements should and can be contracted here. 
 
2.3:  We welcome the announcement by the Drug Treatment Centre Board that two 
of its nurses have graduated as Nurse Prescribers in Addiction. More nurses should 
be recruited and their services should be available in community settings across the 
country, particularly in services outside Dublin.   Restrictions on prescribing 
methadone by these nurses should be re-examined, with their role broadened as 
much as possible.  This in our opinion is a priority action given the reluctance of 
many GPs to provide methadone treatment. 
 
2.4: Clinical training for participating level 1 & 2 GP‟s should include training inputs 
covering the role of community projects in case management and the supports 
projects can offer to GP‟s/Clinics.  It should also include input from clients about their 
positive and negative experiences of methadone treatment so that more patient-
centred services develop. 
 
2.6: Local and Regional Drug Task Forces should co-ordinate regular meetings with 
participating GP‟s and local projects to establish an interface.  All participating GPs 
and projects should be obliged to engage in such meetings with terms of reference 
negotiated and agreed. 
 
2.7: Community detox protocols were developed between voluntary and statutory 
services in the North Inner City Drugs Task Force Area.  These outline how key 
workers/case managers with voluntary service could support prescribing doctors in 
the provision of community based detox for methadone and benzodiazepines.  The 
18 month review was encouraging with doctors, workers and service users having 
positive experiences.  This initiative should be extended to all task force areas and 
properly evaluated, becoming a main element of national drug treatment if it proves 
to be as effective as early outcomes suggest. 
 
 
3. Dosage & Poly-Drug use         
3.1: Services report that many clients are engaged in poly-drug use.  When 
compared to the situation in the mid 1990s (when methadone/physeptone 
prescribing became more widely available through the then EHB) poly drug use is 
the norm now.  It is no longer unusual for clients to be prescribed methadone while 
they also use heroin, cocaine, cannabis, alcohol and tablets (prescribed or illegally 
obtained).  Services are particularly concerned about health risks for clients who are 
prescribed methadone but also engage in hazardous drinking.  
 
CityWide is asking that the new protocol includes directives on best practice when 
the client is using more than just heroin. It also asks that directives be given for best 
practice in prescribing methadone to those who are positively engaged with psycho-
social programmes - particularly where large doses of methadone may limit the 
positive impact of individual and group therapies. 
 
3.2: Although Benzodiazepines are seldom the primary drug of choice, they are 
reported consistently as the second and third most common additional substance 
used.  The Report of the Benzodiazepine Committee issued guidelines for 
prescribing Benzodiazepines.  It is the experience of most projects spoken to by 
CityWide that these guidelines, in most cases, are not being implemented.   
 
Cross-prescribing of Benzodiazepines continues to occur, often undermining the 
positive influence of stabilising doses of methadone.  Co-ordination mechanisms for 
such prescribing need to be implemented and, at least, need to be commented upon 
by the new protocol. 
 
3.3: The impact of reducing methadone as a sanction has to be addressed.  Aside 
from the fact that reducing dosage rapidly can impact on the clients‟ stability, the 
stability of their family, local community as well as causing major upset in the 
projects these clients are engaged, this is an issue of human rights.  For no other 
treatment would the removal of medication be tolerated as an acceptable 
intervention.   
While CityWide agree that nobody should be subject to anti-social, threatening or 
abusive behaviour by clients, we equally agree that removal of opioid replacement 
medications should never be used as a punishment for such behaviour.   
 
3.4: Many of the service providers report an unexplained unwillingness on behalf of 
some prescribing GP‟s to engage in reducing methadone dosage for clients.  This is 
often despite the fact that this is the client‟s stated wish.   This reduction is often 
supported by treatment and rehab service providers and would be conducive to 
supporting the clients care plan.  
 
In some cases, prescribing GPs are reported to have increased the dosage 
prescribed. Service providers have noticed that as a result, some clients are 
reducing dosage themselves (by not taking the full amount prescribed) except when 
they have to go to pharmacies - at which point they take more than they have 
become used to leading to obvious complications.  This is a situation that requires 
immediate attention. 
 
As noted above (see 2.7), community drugs projects are more than willing and able 
to assist GPs in navigating through this process.  Respect for and engagement with 
a client‟s desires regarding their recovery, should be paramount and we feel that a 
response to this situation should be central to the new protocol. 
 
3.5: Clients incentive to detox is often undermined by fear that if they detox they will 
not be able to link back in immediately with local services and programmes.  Projects 
know of clients staying on very low dosage in order to allow them to keep access to 
prescribing services.  Given the complexities of methadone detoxification, clients 
should be allowed, if they relapse within two years, to re-engage with drug services 
as part of aftercare treatment. 
 
3.6: The MTP should be renamed the Opioid Replacement Treatment Protocol with 
the range of medication on offer extended to include other drug therapies like 
Suboxzone and Subutex.  
 
Clear prescribing guidelines should be made widely available to medical and non 
medical services. For example, trials of Buprenorphine (the active ingredient in 
Suboxzone) have proven it to be more effective than other drugs for certain 
populations and may have advantages over methadone for the management of 
opiate withdrawal.   
 
Room should be created in this protocol for emerging and future pharmaco-therapies 
that will be of benefit to drug users in at all stages of recovery.   
 
3.7: The practice of collecting samples for urinalysis by observing the client by 
standing in the cubicle while the client is urinating is degrading and its practice 
should be discontinued.   
 
Again and again, drugs services talk of the impact of taking urine samples from 
clients.  For clients who have been abused (sexually and otherwise) the practice of 
observation for urinalysis is damaging to self-esteem and self-efficacy for recovery. 
While CityWide accepts that knowing the drug status of clients is essential, there are 
many alternatives tests to determine drug use available (including the use of mouth 
swabs) and we strongly suggest a phasing out of urinalysis in favour of whichever 
other chosen method is found to be sufficiently accurate and cost-effective. 
But the current practice must stop. 
 
 3.8 Currently there is no clear appeals process for clients in relation to decisions 
made by prescribing GPs.  This is unfair and contrary to actions 3.1/3.2/3.3 of the 
National Strategy for Service User Involvement in the Irish Health Service 2008-
2013.   
“Service users should be able to articulate their views and be listened to in their 
individual interactions with health care professionals and as key stakeholders where 
decisions are taken about future health service development. The key for service 
users is that they get clear feedback and that they feel their contribution has been 
valued.” (Mary Harney, National Strategy for Service User Involvement in the Irish 
Health Service 2008-2013, page 4) 
 
 
An appeals process should be established for all prescribing decisions affecting 
service users to ensure greater transparency and to address the disempowering 
impact of unilateral decisions 
 
4. Treatment and Rehabilitation in Prisons 
It is acknowledged that depending on the nature of their drug problem that prisoners 
present with different demands for treatment in the prison setting.  This causes 
inconsistencies in the responses on offer to prisoners presenting with problem drug 
use in different parts of the country.  This geographical variation in treatment 
provision is, in part, reflective of some variation in treatment provision in the 
communities/counties in which the prisons are located. 
 
The fact that not all prisons are in a position - or are willing - to provide methadone 
maintenance treatment is an issue that needs to be addressed within this protocol.  
We ask that clear guidelines on the benefits and „how to‟ regarding the provision of 
opioid replacement therapies in prison be provided within the protocol. 
 
4.1 To respond to Action 43 of the National Drug Strategy, a working group was 
established by the IPS to examine how to expand the provision of treatment, 
rehabilitation and other social services and to develop agreed protocols for seamless 
provision of treatment services.   
 
The working group was made up of members of the IPS, Community & HSE. This 
group convened on one occasion only.  It needs to be re-convened so that its work 
can brought to a speedy conclusion.   
 
We believe that such work can enhance the effectiveness of any new opioid 
replacement protocol and assist the IPS in implementing delivery of effective drug 
services to prisoners. 
 
4.2: To ensure that people upon release have full access to thorough care for 
treatment services, the IPS must make contact with relevant Community Prison Link 
Workers before any prisoner is released. Again, community workers are a resource 
that can make drug treatment more effective.  Prison Links workers are a support to 
easing prisoners back into their communities but also assist in the accessing of 
medical services within the community and thereby impacting on the numbers 
overdosing post release. 
 
4.3: Treatment services within prisons must be able to initiate methadone treatment 
for prisoners where a community treatment place is not available upon release. This 
is particularly important where waiting lists are in operation.   
 
There should be no delay or loss of treatment for a person simply because they 
leave prison.  We have had reports of people being retained in prison after they were 
due for release because there was no community treatment place available.  This 
practice is totally unacceptable and should not continue.    
 
4.5 The IPS Drug Policy & Strategy Monitoring Group, which was established to 
consider progress made in the implementation of the Irish Prison Service Drugs 
Policy, must be reconvened and its work completed within an agreed time frame.  
 
5. Data collection 
Data collection systems should be expanded to include the work that community and 
voluntary services undertake, to ensure that data is captured on care plan reviews, 
interagency plans, and service user progression.    
 
 
Summary of Points from Citywide submission: 
1. Access to treatment to be improved 
2. Guidelines on service capacity for clinics 
3. Improved access to flexible harm reduction services to be seen as part of 
methadone provision 
4. Need for consultation and engagement with community drug services 
5. Full engagement with case management 
6. Stable clients to be seen every second week  
7. Further roll-out of nurse-prescribers 
8. Changes to GP training 
9. Interface between drugs services and GPs supported by local and regional 
Drugs Task Forces 
10. Full implementation of Community Detox Protocol as part of Opioid Treatment 
Protocols 
11. Clear guidelines on prescribing doses for poly-drug users (including alcohol) 
12. Clear guidelines on prescribing for drug users engaged in psycho-social 
treatments 
13. Comment from the protocol on prescribing Benzodiazepines with opioid 
replacement therapies. 
14. An end to the practice of the use of reduction in methadone dosage as a 
sanction for unsociable or violent behaviour 
15. Services users should have the  right to have a nominated person (a Service 
Users Advocate) to be involved in their care plans 
16. The protocol addresses the issue of the unwillingness of some GPs to engage 
in reducing dosage when requested by clients 
17. Access to methadone services should be easily available for clients up to two 
years after detoxification should relapse occur 
18. Methadone Treatment Protocol to be renamed the Opioid Replacement 
Therapies Protocol 
19. The current practice of collecting samples for urinalysis by observation is 
degrading and its practice must be discontinued.   
20. The development of a clear and fair appeals process in relation to decisions 
made by prescribers of opioid replacement therapies 
21. A wider availability of opioid replacement therapies in prison settings 
22. The re-engagement of the working group as established by the IPS in relation 
to Action 43 of the National Drug Strategy 
23. Clear protocol for the care of prisoners on leaving prison in relation to access to 
ongoing opioid replacement treatment 
24. Treatment services within prisons must be able to initiate methadone treatment 
for prisoners where a community treatment place is not available upon release 
25. The reconvening of the IPS Drug Policy & Strategy Monitoring Group 
26. Changes to data collection to include care plan data from voluntary and 
community services 
 
For more information about Citywide see our website: www.citywide.ie 
Or contact: 
Citywide Drugs Crisis Campaign 
11, Cadogan Road, 
Fairview, 
Dublin 3 
01 8365090 
Email: ruth@citywide.ie 
Appendix 1 – Local Protocol 
 
Addiction Service 
Health Service Executive 
Northern Area 
2nd Floor Phibsboro Tower 
Phibsboro 
Dublin 7 
Tel: 882 0300 
Fax: 882 0330 
 
 
Joint Working between HSE & Donnycarney Youth Project 
 
In order to ensure a better quality of care for you longer-term and to help you with your 
rehabilitation, the HSE and Donnycarney Youth Project (“DYP”) have developed a joint 
programme that includes treatment and rehabilitation.  The combination of a rehabilitation 
programme alongside a treatment clinic is a unique opportunity for you to address key areas 
of your life.  The rehabilitation team is led by the Manager and Senior Project Worker. 
The treatment clinic is the responsibility of the GP, Nurse, Counsellor and General Assistants.  
The Manager and Senior Project Worker of the Drug Team of DYP attend the clinical team 
meetings in order to discuss relevant issues for your treatment and care.  The clinical team 
in turn also share information with the DYP staff that may be relevant for your rehabilitation 
in the project.  By signing this form you are agreeing to this joint working on your behalf 
between the two teams.  The information shared may include your clinical care details but 
these will be kept strictly confidential by the DYP and HSE teams. 
Client Name:  ___________________________________________________________ 
Address:  ___________________________________________________________ 
  ___________________________________________________________ 
  ___________________________________________________________ 
Key-worker:  ______________________ 
 
Client Signature: ___________________________________  Date: ________________ 
Doctor’s Signature: __________________________ Date: ____________________ 
 
